CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,176 | +106.3% | 20,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,055 | -95.6% | 20,000 | 0.0% | 0.00% | – |
| Q3 2022 | $24,000 | -33.3% | 20,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $36,000 | -10.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $40,000 | -25.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $54,000 | +20.0% | 20,000 | +100.0% | 0.00% | 0.0% |
| Q3 2021 | $45,000 | -22.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $58,000 | -17.1% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $70,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |